Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,774,397
+$24,613,279 QoQ
Shares Held
473,707
+1649.8% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#75
of 756 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Derivatives in EXEL
reported options exposure · as of Dec 31, 2025CallValue
$201,618
CallShares
4,600
PutValue
$245,448
PutShares
5,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. EXEL ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in EXEL
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,774,397 | 473,707 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,161,118 | 27,072 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,454,201 | 398,225 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $245,448 | 5,600 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $201,618 | 4,600 | Call | Defined | 2026-02-13 | |
| 2025-09-30 | $264,320 | 6,400 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $466,690 | 11,300 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $1,129,021 | 25,613 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,550,640 | 42,000 | Call | Defined | 2025-08-27 | |
| 2025-03-31 | $321,204 | 8,700 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $679,320 | 20,400 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $10,623,932 | 319,037 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,368,007 | 168,324 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,009,919 | 89,449 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $619,281 | 26,097 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,064,316 | 44,365 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,457,569 | 66,708 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,045,106 | 54,689 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $357,675 | 22,299 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $1,804,962 | 79,619 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,838,419 | 100,570 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,604,311 | 359,712 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,939,022 | 271,077 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,145,999 | 360,602 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,027,210 | 101,007 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,443,210 | 59,027 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $9,354,129 | 394,024 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,928,157 | 170,044 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||